BioCentury | Oct 5, 2015
Financial News

Genisphere completes venture financing

...Cancer, Ophthalmic Date completed: 2015-10-01 Type: Venture financing Raised: $4 million Investors: Corporate Fuel Partners; Main Line Health WIR...
BioCentury | Jan 28, 2008
Regulation

The Kynapid dilemma

...when they get back to sinus rhythm," Lipicky said. Peter Kowey, chief of cardiology at Main Line Health...
BioCentury | Dec 17, 2007
Regulation

Cardio panel not converted

...an increased probability that a patient will suffer chronic recurrence. Kowey is president of the Main Line Health...
BioCentury | Jun 2, 2003
Finance

The QT mandate

...a surrogate nobody likes very much," Peter Kowey, chief of cardiology at Lankenau Hospital and Main Line Health...
Items per page:
1 - 4 of 4
BioCentury | Oct 5, 2015
Financial News

Genisphere completes venture financing

...Cancer, Ophthalmic Date completed: 2015-10-01 Type: Venture financing Raised: $4 million Investors: Corporate Fuel Partners; Main Line Health WIR...
BioCentury | Jan 28, 2008
Regulation

The Kynapid dilemma

...when they get back to sinus rhythm," Lipicky said. Peter Kowey, chief of cardiology at Main Line Health...
BioCentury | Dec 17, 2007
Regulation

Cardio panel not converted

...an increased probability that a patient will suffer chronic recurrence. Kowey is president of the Main Line Health...
BioCentury | Jun 2, 2003
Finance

The QT mandate

...a surrogate nobody likes very much," Peter Kowey, chief of cardiology at Lankenau Hospital and Main Line Health...
Items per page:
1 - 4 of 4